Generation of Anterior Hindbrain-Specific, Glial-Restricted Progenitor-Like Cells from Human Pluripotent Stem Cells

Wonjin Yun, Wonjun Hong, Daryeon Son, Hui Wen Liu, Seung Soo Kim, Minji Park, In Yong Kim, Dae-Sung Kim, Gwonhwa Song, Seungkwon You

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Engraftment of oligodendrocyte progenitor cells (OPCs), which form myelinating oligodendrocytes, has the potential to treat demyelinating diseases such as multiple sclerosis. However, conventional strategies for generating oligodendrocytes have mainly focused on direct differentiation into forebrain- or spinal cord-restricted oligodendrocytes without establishing or amplifying stem/progenitor cells. Taking advantage of a recently established culture system, we generated expandable EN1- and GBX2-positive glial-restricted progenitor-like cells (GPLCs) near the anterior hindbrain. These cells expressed PDGFRα, CD9, S100β, and SOX10 and mostly differentiated into GFAP-positive astrocytes and MBP-positive oligodendrocytes. RNA-seq analysis revealed that the transcriptome of GPLCs was similar to that of O4-positive OPCs, but distinct from that of rosette-type neural stem cells. Notably, engrafted GPLCs not only differentiated into GFAP-positive astrocytes but also myelinated the brains of adult shiverer mice 8 weeks after transplantation. Our strategy for establishing anterior hindbrain-specific GPLCs with gliogenic potency will facilitate their use in the treatment of demyelinating diseases and studies of the molecular mechanisms underlying glial development in the hindbrain.

Original languageEnglish
Pages (from-to)633-648
Number of pages16
JournalStem cells and development
Volume28
Issue number10
DOIs
Publication statusPublished - 2019 May 15

Fingerprint

Pluripotent Stem Cells
Rhombencephalon
Neuroglia
Oligodendroglia
Stem Cells
Demyelinating Diseases
Astrocytes
Neural Stem Cells
Gene Expression Profiling
Prosencephalon
Multiple Sclerosis
Spinal Cord
Transplantation
RNA
Brain

Keywords

  • astrocytes
  • differentiation
  • glial restricted progenitor cells
  • hindbrain
  • oligodendrocytes

ASJC Scopus subject areas

  • Hematology
  • Developmental Biology
  • Cell Biology

Cite this

Generation of Anterior Hindbrain-Specific, Glial-Restricted Progenitor-Like Cells from Human Pluripotent Stem Cells. / Yun, Wonjin; Hong, Wonjun; Son, Daryeon; Liu, Hui Wen; Kim, Seung Soo; Park, Minji; Kim, In Yong; Kim, Dae-Sung; Song, Gwonhwa; You, Seungkwon.

In: Stem cells and development, Vol. 28, No. 10, 15.05.2019, p. 633-648.

Research output: Contribution to journalArticle

Yun, Wonjin ; Hong, Wonjun ; Son, Daryeon ; Liu, Hui Wen ; Kim, Seung Soo ; Park, Minji ; Kim, In Yong ; Kim, Dae-Sung ; Song, Gwonhwa ; You, Seungkwon. / Generation of Anterior Hindbrain-Specific, Glial-Restricted Progenitor-Like Cells from Human Pluripotent Stem Cells. In: Stem cells and development. 2019 ; Vol. 28, No. 10. pp. 633-648.
@article{09d50b3b5ca543228ba3bede95ce4cfe,
title = "Generation of Anterior Hindbrain-Specific, Glial-Restricted Progenitor-Like Cells from Human Pluripotent Stem Cells",
abstract = "Engraftment of oligodendrocyte progenitor cells (OPCs), which form myelinating oligodendrocytes, has the potential to treat demyelinating diseases such as multiple sclerosis. However, conventional strategies for generating oligodendrocytes have mainly focused on direct differentiation into forebrain- or spinal cord-restricted oligodendrocytes without establishing or amplifying stem/progenitor cells. Taking advantage of a recently established culture system, we generated expandable EN1- and GBX2-positive glial-restricted progenitor-like cells (GPLCs) near the anterior hindbrain. These cells expressed PDGFRα, CD9, S100β, and SOX10 and mostly differentiated into GFAP-positive astrocytes and MBP-positive oligodendrocytes. RNA-seq analysis revealed that the transcriptome of GPLCs was similar to that of O4-positive OPCs, but distinct from that of rosette-type neural stem cells. Notably, engrafted GPLCs not only differentiated into GFAP-positive astrocytes but also myelinated the brains of adult shiverer mice 8 weeks after transplantation. Our strategy for establishing anterior hindbrain-specific GPLCs with gliogenic potency will facilitate their use in the treatment of demyelinating diseases and studies of the molecular mechanisms underlying glial development in the hindbrain.",
keywords = "astrocytes, differentiation, glial restricted progenitor cells, hindbrain, oligodendrocytes",
author = "Wonjin Yun and Wonjun Hong and Daryeon Son and Liu, {Hui Wen} and Kim, {Seung Soo} and Minji Park and Kim, {In Yong} and Dae-Sung Kim and Gwonhwa Song and Seungkwon You",
year = "2019",
month = "5",
day = "15",
doi = "10.1089/scd.2019.0033",
language = "English",
volume = "28",
pages = "633--648",
journal = "Journal of Hematotherapy and Stem Cell Research",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Generation of Anterior Hindbrain-Specific, Glial-Restricted Progenitor-Like Cells from Human Pluripotent Stem Cells

AU - Yun, Wonjin

AU - Hong, Wonjun

AU - Son, Daryeon

AU - Liu, Hui Wen

AU - Kim, Seung Soo

AU - Park, Minji

AU - Kim, In Yong

AU - Kim, Dae-Sung

AU - Song, Gwonhwa

AU - You, Seungkwon

PY - 2019/5/15

Y1 - 2019/5/15

N2 - Engraftment of oligodendrocyte progenitor cells (OPCs), which form myelinating oligodendrocytes, has the potential to treat demyelinating diseases such as multiple sclerosis. However, conventional strategies for generating oligodendrocytes have mainly focused on direct differentiation into forebrain- or spinal cord-restricted oligodendrocytes without establishing or amplifying stem/progenitor cells. Taking advantage of a recently established culture system, we generated expandable EN1- and GBX2-positive glial-restricted progenitor-like cells (GPLCs) near the anterior hindbrain. These cells expressed PDGFRα, CD9, S100β, and SOX10 and mostly differentiated into GFAP-positive astrocytes and MBP-positive oligodendrocytes. RNA-seq analysis revealed that the transcriptome of GPLCs was similar to that of O4-positive OPCs, but distinct from that of rosette-type neural stem cells. Notably, engrafted GPLCs not only differentiated into GFAP-positive astrocytes but also myelinated the brains of adult shiverer mice 8 weeks after transplantation. Our strategy for establishing anterior hindbrain-specific GPLCs with gliogenic potency will facilitate their use in the treatment of demyelinating diseases and studies of the molecular mechanisms underlying glial development in the hindbrain.

AB - Engraftment of oligodendrocyte progenitor cells (OPCs), which form myelinating oligodendrocytes, has the potential to treat demyelinating diseases such as multiple sclerosis. However, conventional strategies for generating oligodendrocytes have mainly focused on direct differentiation into forebrain- or spinal cord-restricted oligodendrocytes without establishing or amplifying stem/progenitor cells. Taking advantage of a recently established culture system, we generated expandable EN1- and GBX2-positive glial-restricted progenitor-like cells (GPLCs) near the anterior hindbrain. These cells expressed PDGFRα, CD9, S100β, and SOX10 and mostly differentiated into GFAP-positive astrocytes and MBP-positive oligodendrocytes. RNA-seq analysis revealed that the transcriptome of GPLCs was similar to that of O4-positive OPCs, but distinct from that of rosette-type neural stem cells. Notably, engrafted GPLCs not only differentiated into GFAP-positive astrocytes but also myelinated the brains of adult shiverer mice 8 weeks after transplantation. Our strategy for establishing anterior hindbrain-specific GPLCs with gliogenic potency will facilitate their use in the treatment of demyelinating diseases and studies of the molecular mechanisms underlying glial development in the hindbrain.

KW - astrocytes

KW - differentiation

KW - glial restricted progenitor cells

KW - hindbrain

KW - oligodendrocytes

UR - http://www.scopus.com/inward/record.url?scp=85065987348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065987348&partnerID=8YFLogxK

U2 - 10.1089/scd.2019.0033

DO - 10.1089/scd.2019.0033

M3 - Article

C2 - 30880587

AN - SCOPUS:85065987348

VL - 28

SP - 633

EP - 648

JO - Journal of Hematotherapy and Stem Cell Research

JF - Journal of Hematotherapy and Stem Cell Research

SN - 1547-3287

IS - 10

ER -